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926Objective: Cancer can involve the airways, causing various degrees of obstruction. Usually, after days or
months of mild to moderate undervalued symptoms, severe dyspnea arises abruptly, imposing an immediate
attempt to restore the airflow regardless of the etiology. This study focuses on the development of a predictive
preintervention model that is useful when deciding whether to perform therapeutic interventional bronchoscopy
in patients with severe central airway obstruction.
Methods: A total of 804 patients who underwent rigid bronchoscopy under general anesthesia to treat severe
neoplastic central airway obstruction from 1990 to 2009 were studied. Electronic records for patients who un-
derwent bronchoscopy were analyzed. The patients were primarily male (n ¼ 618, 76.9%) and the median age
was 62 years. Lung cancer was the most frequent cause of neoplastic airway obstruction (n¼ 645, 81.65%). An
estimate of the probability of individual endoscopic success was made.
Results: Of the 804 patients with severe neoplastic airway obstruction, 681 (84.7%) achieved luminal clear-
ance, and the procedure was considered an endoscopic success. Tracheal involvement (rate ratio, 1.21; range,
1.16-1.27) endoluminal mass (rate ratio, 1.13; range, 1.06-1.12), and extrinsic compression (rate ratio, 1.17;
1.11-1.17) were associated significantly with a favorable endoscopic outcome. Tumor location and any kind
of mucosal infiltration were the main determinants of the predictive preoperative model of intervention success.
Conclusions: Endoscopic characteristics and location of the neoplastic lesions are the major determinants of
patients’ endoscopic outcome. The preintervention model adds to the clinical evaluation an important contribu-
tion to the decision-making process on performing therapeutic interventional bronchoscopy in a critical setting.
(J Thorac Cardiovasc Surg 2013;145:926-32)During the past decade, substantial progress has been made
in the development of new treatment options for patients
with advanced lung cancer.1,2 Ten years ago, most
nonsurgical candidate lung cancer patients had the
expectation of being treated with single-line chemotherapy
plus concurrent, sequential, or palliative radiotherapy3 to
prevent local progression and systemic disease or, at the
minimum, to control symptoms. Currently, more strategic
options and newdrugs4 offermultiple lines of chemo-,main-
tenance, and target-oriented therapies with increasing suc-
cess, tending to individualize lung cancer patient
treatments.5,6 Despite all these therapeutic options, most of
the tumors become uncontrollable, and a significant
number of patients experience tumor-caused airway ob-
struction.7 Central airway involvement is a frequent occur-
rence in lung cancer patients.8 Furthermore, many otherlmonary Service,a Hospital S. Jo~aoMedical Center, Porto, Portugal; and Uni-
y of Oporto Medical School,b Porto, Portugal.
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The Journal of Thoracic and Cardiovascular Surgcancer types metastasize to or invade the tracheobronchial
tree by contiguity.7,9 Intense dyspnea, even life-threatening
asphyxia, obstructive pneumonia, and hemoptysis are
some of the usual complaints that bring these patients to
a physician. The symptoms and signs depend on the charac-
teristics of the tracheobronchial obstruction.10 Usually, after
a period of unvalued mild to moderate signs and symptoms
of airflow obstruction, a critical respiratory limitation is in-
stalled quickly, which leads to an immediate attempt to re-
store airflow to avert risk to the patient’s life, regardless of
the cause.9,10 In this situation, the decision-making process
on whether to intervene is difficult both because of its
urgency as well as the scarcity of clinical features and diag-
nostic means available to guide the bronchoscopy physician
in each particular case. This study focuses on the decision
making to perform therapeutic interventional bronchoscopy
in patientswith neoplastic disease of any etiology that causes
severe central airway obstruction.We analyzed preoperative
clinical parameters to determine their influence on the endo-
scopic outcome. A predictive model was constructed to as-
sess the individual probability of endoscopic success.METHODS
This was a retrospective study (approved by the Hospital S. Jo~ao Ethics
Committee, Institutional Review Board No. 31/2011). Electronic bron-
choscopy records (filled out immediately at the end of the procedure)
and the video endoscopic registry of patients who underwent rigidery c April 2013
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central airway obstruction from 1990 and 2009 were analyzed.
The great majority of the interventions were performed by the authors, as
were the assessment and classification of events occurring before, during, and
after endoscopic interventions. The study was done in the Pulmonary Depart-
ment of theHospital S. Jo~ao, a 1000-beduniversity hospital in Porto, Portugal.
Selection Criteria
Patients were included after retrospective evaluation of electronic
records of bronchoscopy performed with therapeutic intention from 1990
to 2009. Only cases with severe involvement of central airways (trachea,
main carina, left and right main bronchus) were included. Any case with
such an endoscopic neoplastic obstruction that could not be surpassed
with a 4-mm Karl Storz telescope (Tullingen, Germany; at least 75% re-
duction of original tracheobronchial lumen) and did not allow visualization
of the distal airway was deemed as severe involvement.11
Evaluation Criteria
Endoscopic treatment was classified as successful if, at the end of inter-
vention, an 8.5-mm Shapsay rigid bronchoscope (Tullingen, Germany;
10.5-mm external diameter) could pass easily through the neoplastic ob-
struction and the airway lumen remains unchanged after bronchoscope re-
moval (at least 50% improvement). The treatment was considered a failure
when these conditions were not met.
Preoperative Evaluation
All patients were submitted previously to a judicious clinical evaluation
by the pulmonologist responsible for endoscopic treatment. The evaluation
included a clinical history and physical examination, complete blood
count, blood chemistry, activating partial thromboplastin time, chest radi-
ography or chest computed tomography, and, if possible, a review of pre-
intervention endoscopic findings (fiberoptic bronchoscopy).
Intervention
Patients were intubated after anesthetic induction with an 8.5-mm Shap-
say rigid bronchoscope tube (Karl Storz). The intravenous anesthesia proto-
col included prednisolone 1 mg/kg, a bolus of propofol 2 mg/kg, and
succinylcholine 1 mg/kg immediately after anesthetic induction was estab-
lished. Anesthetic maintenance was done using continuous propofol perfu-
sion of 12 mg/kg/hour during the first 10 minutes, 9 mg/kg/hour from 10 to
30 minutes, and 6 mg/kg/hour until the end of the intervention. More iden-
tical succinylcholine doses could be given at anytime according to muscle
activity. Manual jet ventilation through the bronchoscope was used during
the entire intervention. The neoplastic lesions (Figure 1) found inside the air-
ways could assume 3 basic types: mass, defined as an intraluminal tumor;
mucosal infiltration, characterized by vascular engorgement involving the
mucosa and submucosa layers, edema, and irregularity of themucosa caused
by neoplastic cell invasion; and extrinsic compression, when luminal nar-
rowing was caused by external pushing of the airways. More complex neo-
plastic involvement could be identified in the airways as a result of the
association of these 3 basic lesions (Figure 1).
The operative strategy was decided case by case based on the preoper-
ative evaluation. The endoscopic intervention involved instrumental ma-
nipulation with a bronchoscope, forceps, and an aspirator tube to drain
smoke, blood, and small tissue debris, which is common to all types of
treatment (instrumental debulking). A neodymium–yttrium aluminum
garnet (Nd:YAG) laser (20-30 W, in pulses of 5-20 seconds; Laserscope,
San Jose, Calif) was used to promote the coagulation and shrinkage of
the endoluminal lesions.When the obstruction was determined by extrinsic
compression or mucosal infiltration, stents (Dumon [Novatech, La Ciotat,
France], Hood [Hood Laboratories, Pembrook, Mass]) were used.12,13 In
cases of complex lesions, for instance, mass þ extrinsic compression,
laser therapy and mechanical debulking were performed to treat theThe Journal of Thoracic and Caendoluminal mass; a tracheobronchial stent was also considered to deal
with extrinsic compression.
Statistical Analysis
The clinical and demographic characteristics of the patients (Table 1)were
transformed into indicator variables, coded as 1 if the characteristic was pres-
ent and as 0 if not. Gender was coded as 1 for male and as 2 for female. Age
was expressed as median and age interval. A new dichotomous variable, age
75, was coded as 1 if the patient was 75 years or older and as 0 if the patient
was younger than 75 years. The endoscopic outcome was coded as 1 if con-
sidered a success and as 0 if regarded a failure. The interaction of all thesevar-
iables with the interventional bronchoscopy outcome allowed obtaining
a simple summary of their influence on the immediate endoscopic result, ex-
pressed as risk ratios (RRs).14 A logistic regression model was constructed14
to assess the association between the outcome (success/failure) and the pre-
operative patient characteristics. The logistic model we obtained14 was
used to generate outcome estimates for each individual patient submitted to
interventional bronchoscopy. The individual patient outcome estimates could
be obtained by getting the sum of the products of the coefficient of each in-
dependent variable (b1n) included in the logistic model (Table 2) and their
code (X1n)—1 if a particular characteristicwas present and 0 if absent—and





to obtain the in-
dividual probability of endoscopic outcome (STATA Statistics Data Analysis
9.0, College Station, Tex). We used STATA Statistical Data Analysis 9.0 and
BiostatXL MIX 2.0 (availabe at: http://www.meta-analysis-made-easy.com)
to compute all these estimates.
RESULTS
We studied 804 patients during a 20-year period (Table
1). The patients were primarily male (n ¼ 618, 76.9%),
and the median age was 62 years. Lung cancer was the
most frequent neoplastic cause of airway obstruction
(n¼ 645, 81.65%). Given the sudden presentation, the ma-
jority of the patients we studied underwent no more than
a chest radiograph, blood count, biochemical study (iono-
gram, blood urea nitrogen, creatinine, and glucose), and
summary endoscopic evaluation. Clinical clues, such as
symptom exacerbation history, past radiographic images
and computed tomographic scans, or initial endoscopic in-
volvement, which would allow evaluation of how the dis-
ease began and how it evolved to the actual phase, were
rarely available. This lack of information made it difficult
to identify the tumor site of origin, which was of critical im-
portance to bronchoscopy decision making and intervention
outcome. Lobar atelectasis was the more often identified ra-
diologic pattern on the patients we studied (n ¼ 341,
43.27%). Neoplastic airway involvement was observed in
more than 1 site in 202 patients (25.15%; Table 1).
An exophytic tumor was the most frequent single
neoplastic lesion found in the airways of 436 patients
(54.23%; Table 1). The preoperative risk was established7
using the clinical evaluation and some complementary
exams according to the individual patient’s comorbidities.
The patient intervention risk assessmentwas performed af-
ter preoperative respiratory, cardiovascular, and hematologic
clinical evaluation.7Most of the patients we studied (n¼ 492,
63.73%) had an acceptable intervention risk.rdiovascular Surgery c Volume 145, Number 4 927
FIGURE 1. Endoscopic lesions: mass (intraluminal tumor), infiltration (vascular engorgement, edema, mucosal irregularity), compression (external tumor
compression), and complex lesions (massþ infiltration, massþcompression, compressionþ infiltration).
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of the airways submitted to endoscopic treatment, 681
(84.7%) obtained luminal clearance of at least 50% of
the original airway (Table 1), and their surgeries were con-
sidered endoscopic successes. The overwhelming majority
of the patients who underwent interventional bronchoscopy
had no adverse effects and recovered quickly and in a sus-
tainable way, returning to their reference hospital within
3 hours after the procedure. The single perioperative death
we had was caused bymassive uncontrollable bleeding after
a debulking attempt to clear the distal end of the left main
bronchus (Table 2). Another death occurred as a result of
cardiorespiratory arrest during anesthetic recovery.
Figure 2 shows the interaction between each patient char-
acteristic and the bronchoscopy outcome. Female gender
(RR, 1.07), tracheobronchial obstruction of esophageal
origin (RR, 1.13), tracheal involvement (RR, 1.21), endo-
bronchial mass (RR, 1.13), and extrinsic compression
(RR, 1.17) were associated significantly with a favorable
patient outcome.
The preintervention patient characteristics were used to
construct a logistic model to predict the success or failure
of performing a bronchoscopic therapeutic intervention to
solve a severe neoplastic tracheobronchial obstruction. The
model (Table 2) obtained points out 3 tumor localizations
(tracheal, right main bronchus, and left main bronchus) and
the presence of any kind of mucosal infiltration as the most
important predictors of therapeutic bronchoscopic success.
Using these logistic estimates (Table 2), the probability
of an individual patient with a severe malignant tracheal ob-
struction without endoscopic evidence of mucosal infiltra-
tion to get a good endoscopic result could be computed:
½ð1:2531Þþð1:3830Þþð0:6330Þþð2:4430Þ
þð1:4430Þþð1:1430Þþ2:65 ¼ 3:90;928 The Journal of Thoracic and Cardiovascular Surgwhich indicates a probability of success of just less than
100% (Figure 3). On the other hand, a patient with left
main bronchus obstruction by a mass and mucosal infiltra-
tion could have a much smaller probability of success:
½ð1:2530Þþð1:3831Þþð0:6330Þþð2:4430Þ
þð1:4431Þþð1:1430Þþ2:65 ¼0:17;
corresponding to an intervention success probability of less
than 50% (Figure 3).DISCUSSION
Lung cancer is the main cause of cancer death in the Por-
tuguese male population.15 One of the most remarkable
characteristics of a tumor spreading inside the airways is
theway symptoms arise, many times in an abrupt and severe
manner, after days or months of an overlooked mild evolu-
tion. This behavior demands a difficult prompt decision,
taking into account the patient’s complexity resulting not
only from that particular tracheobronchial obstruction but
also from performance status, comorbidities, and implica-
tion on life expectation. The challenge that this decision
puts on such an emergency situation does not meet with
accurate guidelines in the medical literature.16-21 Most of
the published studies focus on the technical means,12 the
strategy and different skills associated with the available
treatments,16-19 the complications that may occur,9,10,12,22
and the outcomes and their influence on the prognosis of
the disease.18 Despite the accumulated experience the sur-
geon may have, the decision to intervene in these patients
remains a major challenge for many reasons other than
the performance of the intervention itself. A miscalculation
can result in a situation of no return.
To our knowledge, this is the first time a predictive model
of success/failure in interventional bronchoscopy for severeery c April 2013
TABLE 1. Patient data
Characteristic (code) No. of cases (%) Success, n (%) Failure, n (%) Missing, n (%)
Hospital origin 60 (7.50)
H.S. Jo~ao (1) 314 (42.20) 266 (84.71) 48 (15.29)
Other (0) 430 (57.80) 361 (83.95) 69 (16.05)
Age, y (median, 26 y; range, 20-98 y)
Age category<75 y (0) 662 (88.98) 561 (84.74) 101 (15.26) 60 (7.50)
Age category 75 y (1) 82 (11.02) 67 (81.71) 15 (18.29) 0
Sex
Male (1) 618 (76.87) 515 (83.33) 103 (16.67)
Female (2) 186 (23.13) 166 (89.25) 20 (10.75)
Tumor type (*) 14 (1.70)
Lung (1/0) 645 (81.65) 537 (83.26) 108 (16.74)
Thyroid (1/0) 11 (1.39) 11 (100.00) 0 (0.00)
Carcinoid (1/0) 14 (1.77) 13 (92.86) 1 (7.14)
Metastasis (1/0) 25 (3.16) 19 (76.00) 6 (24.00)
Esophagus (1/0) 70 (8.86) 66 (94.29) 4 (5.71)
Other (1/0) 25 (3.16) 23 (92.00) 2 (8.00)
Image (X-ray or CT scan) 16 (1.90)
Atelectasis (1) 341 (43.27) 272 (79.77) 69 (20.23)
Other (2) 447 (56.73) 395 (88.37) 52 (11.63)
Location (*) 1 (0.10)
Trachea (1/0) 224 (27.90) 217 (96.80) 7 (3.13)
Carina (1/0) 25 (3.11) 25 (100.00) 0
RMB (1/0) 173 (21.54) 145 (83.82) 28 (16.18)
LMB (1/0) 202 (25.15) 171 (84.65) 31 (15.34)
Multiple locations (1/0) 179 (22.29) 122 (68.16) 57 (31.84)
Endoscopic lesion (*) 0
Mass 436 (54.23) 390 (89.45) 46 (10.55)
Extrinsic compression 52 (6.47) 51 (98.08) 1 (1.92)
Mucosal infiltration 28 (3.48) 15 (53.57) 13 (46.43)
Massþcompression 80 (9.95) 73 (91.25) 7 (8.75)
Massþ infiltration 148 (18.41) 100 (67.56) 48 (32.43)
Compressionþ infiltration 60 (7.46) 52 (86.66) 8 (13.34)
Intervention risk 32 (3.80)
Basal (0) 492 (63.73) 412 (83.74) 80 (16.26)
Risk (1) 280 (36.27) 242 (86.43) 38 (13.57)
Treatment (*) 0
Laser (1/0) 598 (75.51) 485 (81.10) 113 (18.90)
Stent (1/0) 129 (16.28) 126 (97.67) 3 (2.33)
Laserþstent (1/0) 65 (8.21) 64 (98.46) 1 (1.54)
Instrumental debulking (1/0) 12 (1.48) 10 (83.33) 2 (16.67)
Outcome 681 (84.70) 123 (15.30) 0
(*) Characteristics were transformed in indicator variables coded as 1 if the characteristic is present and 0 if it is not.CT, Computed tomography; RMB, right main bronchus; LMB,
left main bronchus.
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When we thought of doing this study, aimed at determining
intervention criteria for performing therapeutic bronchos-
copy in patients with respiratory distress caused by
neoplastic involvement, many questions arose: Which strat-
egy should we use? Which patients should be included?
Which outcome would be acceptable to consider as an en-
doscopic therapeutic success? How could we assess accu-
rately the outcome of the interventions?
A clinical trial would be unethical. A prospective study
would be ideal; however, the number of accruable newThe Journal of Thoracic and Cacases each year (30-40) made it impossible to get results
in due time. The only possibility lay in data from electronic
bronchoscopy patient records started at our institution in
1988, which allowed us to perform this study, albeit retro-
spectively. Nevertheless, the information for each patient
procedure was registered immediately after the bronchos-
copy, thus minimizing the possible influence of information
bias or misclassification of events measured at this distance
in time. Another unique strength of the study lies in the
fact that we performed the overwhelming majority of the
interventions and hence their registry, thus reducingrdiovascular Surgery c Volume 145, Number 4 929
TABLE 2. Interventional bronchoscopy prediction model
Logistic regression
Correct model classification 84%
Coefficient Standard error Wald P value
No. obs. 717 Prob.>c20.000
Variables Exp (coefficient) Exp (coefficient) 95% CI
Trachea 1.247 0.458 2.720 .007 3.408 1.416-8.555
Left main bronchus 1.377 0.285 23.257 .000 0.252 0.144-0.442
Right main bronchus 0.626 0.318 3.884 .049 0.535 0.287-0.997
Mucosal Infiltration 2.441 0.475 26.435 .000 0.087 0.034-0.221
Massþ infiltration 1.442 0.255 31.899 .000 0.236 0.143-0.390
Compressionþ infiltration 1.142 0.464 6.052 .014 0.319 0.129-0.793
Constant 2.650 0.259 140.313 .000
The location of the tumor and the morphology of the tracheobronchial lesions are determinants of the intervention success. Exp, Exponential; CI, confidence interval.
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vention bronchoscopy procedure is always difficult to
quantify. The best solution we found was to determine 2 ob-
jective criteria that could be identified easily in patients’
electronic records and video registry. Was the tracheobron-
chial obstruction overcome? At the end of the intervention,
was at least 50% of the original lumen recovered? To con-
sider a tracheobronchial lumen clearance of 50% as a good
endoscopic result may be criticized. However, scientific
knowledge on fluid flows through tubes allows us toFIGURE 2. Interventional bronchoscopy group analysis. Risk ratios in perform
the presence of a particular patient characteristic. RMB, Right main bronchus;
930 The Journal of Thoracic and Cardiovascular Surgrecognize that any small clearance of a bronchus may cor-
respond to an important gain in breathing efficiency that
may, in fact, be clinically relevant.
The physiologic basis of this assumption is based on
Poiseuille’s law.23 According to this law, flow is related to
perfusion pressure, radius, length, and viscosity. In the
human body, however, flow does not conform exactly to
this relationship. Nevertheless, the relationship shows
clearly the dominant influence of radius on resistance and
flow. This means that achieving even a small clearance ofing bronchoscopy to treat severe tracheobronchial obstruction according to
LMB, left main bronchus; CI, confidence interval.
ery c April 2013
FIGURE 3. Interventional Bronchoscopy Success. Calculate the characteristic score by multiplying each logistic coefficient by 1 (if the characteristic is
present) or by 0 (if the characteristic is absent). Sum all the characteristic scores to get the total score for an individual patient. Refer to the graph or the table
to get patient’s probability of endoscopic success. RMB, Right main bronchus; LMB, left main bronchus.
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which is clinically relevant.
One of the most significant limitations of this study is
related to the patient selection done before the procedure.
We submitted to interventional bronchoscopy only those
patients who we were strongly convinced would have very
good chances of benefiting from the treatment (patients
with significant respiratory distress [extreme shortness of
breath, polypnea, stridor, wheezing, and, sometimes,
hypoxia], known severe malignant tracheobronchial
obstruction based on fiber-optic bronchoscopy/computed
tomographic scan, no other explanation for respiratory
distress, and acceptablegeneral condition performance status
0-3). Using these criteria, the patients presented here do not
represent the entire spectrum of patients potentially ap-
proachable by interventional bronchoscopy, but rather those
that, using preoperative clinical assessment, were classified
as possible to benefit from this intervention. However, the
model does seem to predict failure as well as success in the
included patients, meaning worse cases would have been tar-
geted easily by this statistical instrument. This predictive
model points out the characteristics of the neoplastic lesion
and the location of the obstruction as main determinants of
intervention bronchoscopy success. The estimates provided
by this model can be a very useful complement to the prein-
tervention clinical evaluation toward making a decision on
whether to perform interventional therapeutic bronchoscopy
in patients with severe and complex conditions.
In conclusion, as mentioned, the tracheobronchial tumor
location and the characteristics of the lesions areThe Journal of Thoracic and Cadeterminants of the endoscopic success of therapeutic inter-
ventional bronchoscopy. The use of the predictive rule pro-
posed here might be a useful instrument, in addition to
clinical evaluation, in increasing the accuracy of decision
making on the performance of therapeutic bronchoscopy
to treat severe neoplastic airway obstruction.
We thank Prof Paulo Dinis Oliveira for the final preparation of
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